V A Bzik1, D J Brayden2. 1. School of Veterinary Medicine and Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland. 2. School of Veterinary Medicine and Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland. david.brayden@ucd.ie.
Abstract
PURPOSE: 1-phenyl piperazine (PPZ) emerged from a Caco-2 monolayer screen as having high enhancement potential due to a capacity to increase permeation without significant toxicity. Our aim was to further explore the efficacy and toxicity of PPZ in rat ileal and colonic mucosae in order to assess its true translation potential. METHODS: Intestinal mucosae were mounted in Ussing chambers and apparent permeability coefficient (Papp) values of [(14)C]-mannitol and FITC-dextran 4 kDa (FD-4) and transepithelial electrical resistance (TEER) values were obtained following apical addition of PPZ (0.6-60 mM). Exposed issues were assessed for toxicity by histopathology and lactate dehydrogenase (LDH) release. Mucosal recovery after exposure was also assessed using TEER readings. RESULTS: PPZ reversibly increased the Papp of both agents across rat ileal and distal colonic mucosae in concentration-dependent fashion, accompanied by TEER reduction, with acceptable levels of tissue damage. The complex mechanism of tight junction opening was part mediated by myosin light chain kinase, stimulation of transepithelial electrogenic chloride secretion, and involved activation of 5-HT4 receptors. CONCLUSIONS: PPZ is an efficacious and benign intestinal permeation enhancer in tissue mucosae. However, its active pharmacology suggest that potential for further development in an oral formulation for poorly permeable molecules will be difficult.
PURPOSE:1-phenyl piperazine (PPZ) emerged from a Caco-2 monolayer screen as having high enhancement potential due to a capacity to increase permeation without significant toxicity. Our aim was to further explore the efficacy and toxicity of PPZ in rat ileal and colonic mucosae in order to assess its true translation potential. METHODS: Intestinal mucosae were mounted in Ussing chambers and apparent permeability coefficient (Papp) values of [(14)C]-mannitol and FITC-dextran 4 kDa (FD-4) and transepithelial electrical resistance (TEER) values were obtained following apical addition of PPZ (0.6-60 mM). Exposed issues were assessed for toxicity by histopathology and lactate dehydrogenase (LDH) release. Mucosal recovery after exposure was also assessed using TEER readings. RESULTS:PPZ reversibly increased the Papp of both agents across rat ileal and distal colonic mucosae in concentration-dependent fashion, accompanied by TEER reduction, with acceptable levels of tissue damage. The complex mechanism of tight junction opening was part mediated by myosin light chain kinase, stimulation of transepithelial electrogenic chloride secretion, and involved activation of 5-HT4 receptors. CONCLUSIONS:PPZ is an efficacious and benign intestinal permeation enhancer in tissue mucosae. However, its active pharmacology suggest that potential for further development in an oral formulation for poorly permeable molecules will be difficult.
Authors: Susan B Fowler; Stephen Poon; Roman Muff; Fabrizio Chiti; Christopher M Dobson; Jesús Zurdo Journal: Proc Natl Acad Sci U S A Date: 2005-07-08 Impact factor: 11.205
Authors: Linda M Feighery; Sean W Cochrane; Teresa Quinn; Alan W Baird; Daniel O'Toole; Sian-Eleri Owens; Diarmuid O'Donoghue; Randall J Mrsny; David J Brayden Journal: Pharm Res Date: 2008-06 Impact factor: 4.200
Authors: Romano Di Fabio; Cristiana Griffante; Giuseppe Alvaro; Giorgio Pentassuglia; Domenica A Pizzi; Daniele Donati; Tino Rossi; Giuseppe Guercio; Mario Mattioli; Zadeo Cimarosti; Carla Marchioro; Stefano Provera; Laura Zonzini; Dino Montanari; Sergio Melotto; Philip A Gerrard; David G Trist; Emiliangelo Ratti; Mauro Corsi Journal: J Med Chem Date: 2009-05-28 Impact factor: 7.446
Authors: Sam Maher; Rory Kennelly; Victoria A Bzik; Alan W Baird; Xuexuan Wang; Desmond Winter; David J Brayden Journal: Eur J Pharm Sci Date: 2009-09-06 Impact factor: 4.384
Authors: Heron D Baumgarten; Christina M Wright; Avery C Rossidis; Kendall M Lawrence; Aimee G Kim; Ali Y Mejaddam; Patrick E McGovern; Melissa N Orr; Barbara E Coons; Zoya Butt; Haiying Li; Grace Hwang; Antoneta Radu; Lauren J Brown; Ronald C Rubenstein; William H Peranteau; Marcus Davey; Robert O Heuckeroth; Alan W Flake Journal: Cell Mol Gastroenterol Hepatol Date: 2020-05-28